December 21, 2011
Our legal department is under pressure to cut costs and increase predictability. Should we ask law firms to move away from the billable hour?
November 02, 2011
My company is looking to outsource patent filing and drafting work abroad – what are the practical and legal pitfalls to avoid?
September 26, 2011
What is the best IP protection for fashion designs in the US and Europe?
September 01, 2011
July 14, 2011
Would encouraging consumers to report counterfeiting help solve the problem or be a bad PR move?
May 31, 2011
When is it worth using the PCT, PPHs or just filing nationally?
May 03, 2011
It happened to Tylenol, Firestone and Vioxx. What can trade mark counsel do to minimise the effect of a product recall on a brand?
March 30, 2011
I know I need to register a brand before someone else does, but should I translate, transliterate or use a nick name?
March 01, 2011
Around the world I find people selling my company’s goods without our permission and at a profit. What’s the best way to shut them down?
January 27, 2011
I’ve joined a brand that frequently appears in films and TV programmes. Should I be actively managing this?
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International